Fingerprint
Dive into the research topics of 'Phase 1 study of romidepsin plus erlotinib in advanced non-small cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 1 study of romidepsin plus erlotinib in advanced non-small cell lung cancer
David E. Gerber, David A. Boothman, Farjana J. Fattah, Ying Dong, Hong Zhu, Rachel A. Skelton, Laurin L. Priddy, Peggy Vo, Jonathan E. Dowell, Venetia Sarode, Richard Leff, Claudia Meek, Yang Xie, Joan H. Schiller
Research output: Contribution to journal › Article › peer-review
40
Scopus
citations